You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN--(BUSINESS WIRE)--The "Global C5 Complement Inhibitors Drug Market Opportunity, Drug Price, Sales & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insight on clinical and non-clinical factors that are driving the global C5 Complement Inhibitors market and its impact on the global pharmaceutical market landscape. The report has been prepared in a view to deeply profile the current market trends along with the sales insight on 3 commercially available C5 Complement Inhibitors with their regional level revenue, market share and the clinical profile. Report Highlights: Companies Mentioned The arrival of C5 complement inhibitor drug market for the need of the patient population all over the world is believed to be capable of bearing all the challenges that the pharmaceutical industry has been witnessing for long period of time. Not only cancer, but the therapeutic approach developed by the researchers few years back is believed to be having subtle impact on several different kidney diseases and many more that have huge mortality rate. Over a small period of time, the respective therapeutic approach is also being focused by some of the big pharmaceutical players which indeed have led to a traditional increase in the rate of research and development activities for the same. It is predicted that in the next few years of time period, the entire therapeutic approach which at the current period of time is only having few clinical drugs will be packed with excessive number of inhibitors, driving the way of the respective therapy market to become one of the pioneering leaders. Some of the parameters that are estimated to get improved with coming time for the substantial improvement of the overall therapy are: R&D productivity, inhibitor cost reduction, as well as influx of major pharmaceutical players and biotech companies, focused towards adapting the therapeutic approach for further investigation against different diseases with high mortality and prevalence rate. The report predicts that the therapeutic approach despite of being completely novel, when compared with other old and traditional therapies is accelerating at a very high rate with respect to market size and opportunities. In addition, the global sales of the C5 complement inhibitor drug market is growing at steadily, apparently depicting the increase in the consumption rate of the drugs by the patients. Exclusive demand of the therapeutic approach such as C5 complement inhibitor therapy and the presence of few inhibitor drugs in the market is also predicted to align the entire market toward becoming more dynamic and drastic. It is predicted that in the next few years, several investigational drugs will enter late-stage clinical development phase, which will eventually cause a projectile inclination in the rate of market growth and opportunities highly lacking in the current pharmaceutical industry. Key Topics Covered: 1. Introduction to C5 Complement Inhibitors 1.1 Overview 1.2 Evolution of C5 Complement Inhibitors 2. Mechanism of C5 Complement Inhibitors 2.1 Mechanism of Complement Activation 2.2 Inhibition of C5 Complement 3. Global C5 Complement Inhibitors Market Sales Insight 3.1 Current Market Scenario 3.2 Future Market Opportunity 3.3 Market Opportunity by Indication 3.3.1 Paroxysmal Nocturnal Hemoglobinuria 3.3.2 Atypical Hemolytic Uremic Syndrome 3.3.3 Neuromyelitis Optica Spectrum Disorder 3.3.4 Generalized Myasthenia Gravis 4. Global C5 Complement Inhibitors Clinical Trials Overview 4.1 By Company 4.2 By Country 4.3 By Patient Segment 4.4 By Phase 5. US - C5 Complement Inhibitors Market Analysis 5.1 Current Market Scenario 5.2 Future Market Opportunity 6. Europe - C5 Complement Inhibitor Market Analysis 6.1 Current Market Scenario 6.2 Future Market Opportunity 7. Asia Pacific - C5 Complement Inhibitor Market Analysis 7.1 Current Market Scenario 7.2 Future Market Opportunity 8. Soliris (Eculizumab) 8.1 Overview 8.2 Patent Exclusivity & Designations 8.3 Dosage & Price Analysis 8.3.1 Branded (Soliris) 8.3.2 Biosimilar (Elizaria) 8.4 Global Sales Analysis 8.5 Soliris Regional Sales Analysis 8.5.1 US 8.5.2 Europe 8.5.3 Asia Pacific 8.5.4 Rest of World 9. Ultomiris (Ravulizumab) 9.1 Overview 9.2 Patent Exclusivity & Designation 9.3 Dosage & Price Analysis 9.4 Global Sales Analysis 9.5 Soliris Regional Sales Analysis 9.5.1 US 9.5.2 Europe 9.5.3 Asia Pacific 9.5.4 Rest of World 10. Global C5 Complement Inhibitors Clinical Trials Insight 10.1 Preclinical 10.2 Phase-I 10.3 Phase-II 10.4 Phase-II/III 10.5 Phase-III 11. Marketed C5 Complement Inhibitors Clinical Insight 11.1 Eculizumab 11.2 Ravulizumab 11.3 Eculizumab Biosimilar 12. C5 Complement Inhibitors Market Dynamics 12.1 C5 Complement Inhibitors Market Drivers 12.2 Challenges for C5 Complement Inhibitor Market 13. C5 Complement Inhibitor Market Future Outlook 14. Competitive Landscape For more information about this report visit https://www.researchandmarkets.com/r/fgwj6f

Answer: Global C5 Complement Inhibitors Drug Market to 2026 - Opportunity, Drug Price, Sales & Clinical Trials Insights - ResearchAndMarkets.com